142 related articles for article (PubMed ID: 38010470)
1. Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatment.
Qiu J; Feng X; Chen H; Liu W; Liu W; Wu L; Gao X; Liu Y; Huang Y; Gong H; Qi Y; Xu Z; Zhao Q
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300404. PubMed ID: 38010470
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel α-carboline derivatives as glycogen synthase kinase-3β inhibitors for the treatment of Alzheimer's disease.
Chen H; Yu C; Liu W; Zhu C; Jiang X; Xu C; Liu W; Huang Y; Xu Z; Zhao Q
Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200156. PubMed ID: 35836098
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment.
Liu W; Tian L; Wu L; Chen H; Wang N; Liu X; Zhao C; Wu Z; Jiang X; Wu Q; Xu Z; Liu W; Zhao Q
Bioorg Chem; 2022 Dec; 129():106168. PubMed ID: 36191431
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
[TBL] [Abstract][Full Text] [Related]
7. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of thieno[3,2-
Yan N; Shi XL; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1724-1736. PubMed ID: 35698879
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation.
Qiu N; Qian C; Guo T; Wang Y; Jin H; Yao M; Li M; Guo T; Lv Y; Si X; Wu S; Wang H; Zhang X; Xia J
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132024. PubMed ID: 38704072
[TBL] [Abstract][Full Text] [Related]
10. Design, Bio-evaluation and Molecular Dynamics Simulation of Novel GSK-3β Inhibitors.
Lyu W; Li Q; Li Q; Chen Y; Wang Y; Tang T; Feng F; Chi H; Li Y; Liu W; Sun H
Mol Inform; 2021 Dec; 40(12):e2060031. PubMed ID: 34323388
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease.
Wu X; Ze X; Qin S; Zhang B; Li X; Gong Q; Zhang H; Zhu Z; Xu J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675602
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.
Wang M; Liu T; Chen S; Wu M; Han J; Li Z
Eur J Med Chem; 2021 Jan; 209():112874. PubMed ID: 33017743
[TBL] [Abstract][Full Text] [Related]
13. ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.
Demuro S; Sauvey C; Tripathi SK; Di Martino RMC; Shi D; Ortega JA; Russo D; Balboni B; Giabbai B; Storici P; Girotto S; Abagyan R; Cavalli A
Eur J Med Chem; 2022 Feb; 229():114054. PubMed ID: 34959172
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
15. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
[TBL] [Abstract][Full Text] [Related]
16. An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease.
Liu X; Lai LY; Chen JX; Li X; Wang N; Zhou LJ; Jiang XW; Hu XL; Liu WW; Jiao XM; Qi ZT; Liu WJ; Wu LM; Huang YG; Xu ZH; Zhao QC
Neuropharmacology; 2023 Jul; 232():109525. PubMed ID: 37004752
[TBL] [Abstract][Full Text] [Related]
17. Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
Cheng Z; Han T; Yao J; Wang K; Dong X; Yu F; Huang H; Han M; Liao Q; He S; Lyu W; Li Q
Eur J Med Chem; 2024 Feb; 265():116065. PubMed ID: 38160617
[TBL] [Abstract][Full Text] [Related]
18. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-AD effects of dual inhibitor targeting glutaminyl cyclase/GSK-3β.
Xie Y; Chen C; Lin S; Yu X; Ye S; Chen X; Ouyang N; Xiong W; Li C; Xu C; Song G; Wu H
Eur J Med Chem; 2023 Feb; 248():115089. PubMed ID: 36638710
[TBL] [Abstract][Full Text] [Related]
20. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
